$0.27
▼ -3.4% Today
as of Jul 23, 14:18 ET
Last 30 days
Recent Press Releases & News
Ensysce Biosciences Receives Final $5.3 Million NIDA Funding Installment for PF614-MPAR Development
Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant
ENSC Receives Vital Funding for Drive to Commercialization
Overview
52-week range
$0.23
$2.75
2% of range
Avg surprise (last 3)
+35.1%
Avg reaction (last 2)
-2.2%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-0.52 | $-0.73 | +28.8% | +62.6% | +1.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.29 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-0.79 | $-1.02 | +22.6% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-1.39 | $-3.02 | +54.0% | — | -5.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $1.00 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-3.35 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-8.21 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.87 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.98 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | OTHER | -$0.50 | -$0.79 | +36.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $960,999 | — | $493,104 | $1M | $1M | — | $3M | $181,797 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | — | $-4M | $-2M | $-2M | — | $644,746 | $-2M |
| Net income | — | — | — | — | — | — | — | — |
| EPS (diluted) | $-0.52 | — | $-1.29 | $-0.79 | $-1.39 | — | $1.00 | $-3.35 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $745,482 | $4M | $2M | $2M | $3M | $4M | $4M | $1M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $2M | $7M | $3M | $5M | $4M | $5M | $9M | $2M |
| Total assets | $2M | $7M | $3M | $6M | $5M | $6M | $9M | $3M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3M | $5M | $2M | $3M | $2M | $2M | $3M | $1M |
| Total equity | $-340,042 | $3M | $1M | $3M | $3M | $4M | $7M | $2M |
Implied volatility — last 90 days
No IV snapshots yet for ENSC.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.